During the last few years, significant improvements have been made in diagnosing ophthalmic conditions such as glaucoma, macular degeneration, and other retinal disorders. The market has been fueled by favorable reimbursement of ocular devices and surgery in the U.S. and more excellent healthcare insurance coverage in Europe.